COMMUNIQUÉS West-GlobeNewswire

OSE Immunotherapeutics Highlights Abstracts Selected for Presentation at ASCO 2025

23/04/2025 - 18:00

OSE Immunotherapeutics Highlights Abstracts Selected for Presentation at ASCO 2025 Featuring proprietary asset Tedopi® and two partnered SIRPα inhibitor assets with Boehringer Ingelheim NANTES, France – April 23, 2025, [...]

EssilorLuxottica: Chiffre d’affaires T1 2025 - Forte croissance du chiffre d'affaires au premier trimestre

23/04/2025 - 18:00

Forte croissance du chiffre d'affaires au premier trimestre Chiffre d'affaires du Groupe en hausse de +8,1 % à taux de change courants et de +7,3 % à taux de change constants 1 au T1 Solide croissance des segments [...]

EssilorLuxottica: Q1 2025 Revenue - Strong revenue growth in the first quarter

23/04/2025 - 18:00

Strong revenue growth in the first quarter Group’s revenue up 8.1% at current and 7.3% at constant exchange rates 1 in Q1 Sound growth in both PS and DTC channels, with comparable-store sales 3 up 8% EMEA growing 10% at [...]

Artax Biopharma to present Phase 2a data on Nck modulator AX-158, establishing novel mechanism of action in autoimmune disease at the 2025 SID Annual Meeting

23/04/2025 - 18:00

Late breaker abstract presentation to showcase clinical validation of first-in-class oral small molecule AX-158 in cohort of patients with psoriasis Full dataset to expand on previously announced topline results, [...]

La molécule AB8939 obtient la désignation de médicament orphelin auprès de l'EMA dans le traitement de la leucémie myéloïde aigue

23/04/2025 - 18:59

COMMUNIQUE DE PRESSE LA MOLECULE AB8939 OBTIENT LA DESIGNATION DE MEDICAMENT ORPHELIN DANS L’UNION EUROPEENNE AUPRES DE L’AGENCE EUROPEENNE DES MEDICAMENTS (EMA) DANS LE TRAITEMENT DE LA LEUCEMIE MYELOÏDE AIGUE Paris, [...]

AB Science announces that EMA granted orphan drug status to AB8939 for the treatment of acute myeloid leukemia

23/04/2025 - 18:59

PRESS RELEASE EUROPEAN MEDICINES AGENCY (EMA) HAS GRANTED ORPHAN DRUG DESIGNATION IN THE EUROPEAN UNION FOR AB8939 IN THE TREATMENT OF ACUTE MYELOID LEUKEMIA Paris, April 23, 2025, 6.45pm CET AB Science SA (Euronext - [...]

John Flack Appointed CFO of Advanced Medical Pricing Solutions

23/04/2025 - 19:02

PHOENIX, April 23, 2025 (GLOBE NEWSWIRE) -- Advanced Medical Pricing Solutions (“AMPS”), a diversified healthcare technology company supporting transparent, affordable medical and prescription benefits, announced today [...]

Prime Biome Reviews (We Tried It for 115 Days) Here’s Our Month-by-Month Review, Unexpected Results, And Benefits!

23/04/2025 - 19:04

ALBANY, N.Y., April 23, 2025 (GLOBE NEWSWIRE) -- Prime Biome is a dietary supplement designed to support skin and gut health by achieving microbial equilibrium in the body. It is loaded with probiotics for clear skin [...]

Pineal XT Reviews (WARNING) Is It Safe And Worth Trying? Understanding Its Natural Ingredients And Benefits!

23/04/2025 - 19:04

ALBANY, N.Y., April 23, 2025 (GLOBE NEWSWIRE) -- Pineal XT is a natural dietary capsule developed and designed to support cognitive functions. It blends in scientifically proven ingredients to enhance brain power, [...]

SynoGut Reviews (ALERT) Consumer Reports Reveal Unexpected Truths Behind Its Ingredients And Side Effects

23/04/2025 - 19:04

CANTON, Ohio, April 23, 2025 (GLOBE NEWSWIRE) -- SynoGut is a gut health support supplement that provides a natural way to support a healthy digestive system. The dietary formula is a combination of natural herbs, [...]

Science Translational Medicine Study Funded by the Bay Area Lyme Foundation Identifies FDA-approved Piperacillin as More Effective, Targeted Treatment for Lyme Disease

23/04/2025 - 20:00

An additional Science Translational Medicine study also funded by Bay Area Lyme Foundation uncovers how lingering bacterial cell wall molecules may contribute to chronic Lyme symptoms PORTOLA VALLEY, Calif., April 23, [...]

Rezolute Announces Pricing of Offering of $90 Million of Common Stock and Pre-Funded Warrants

23/04/2025 - 14:05

NEW YORK, April 23, 2025 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or the “Company”), a late-stage biopharmaceutical company committed to developing novel, transformative therapies for serious rare [...]

VivoSim to Carry Forward Organovo 3D Bioprinting

23/04/2025 - 14:05

SAN DIEGO, April 23, 2025 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO) (the “Company”) announced that it will carry forward its 3D bioprinting and legacy technology as VivoSim Labs, Inc. A name change of [...]

Hospice Choices: VITAS® Healthcare Expands in Austin, Texas

23/04/2025 - 14:14

AUSTIN, Texas, April 23, 2025 (GLOBE NEWSWIRE) -- Responding to the growing demand for high-quality hospice care in Central Texas, VITAS Healthcare has expanded its reach in the Austin area by opening a new [...]

OneMedNet and Protege Partner to Advance the Future of AI-Driven Healthcare with Real-Time, Multimodal Data

23/04/2025 - 14:15

MINNEAPOLIS, April 23, 2025 (GLOBE NEWSWIRE) -- OneMedNet, a leader in AI-powered Real-World Data, has announced a strategic partnership with Protege, the AI training data platform, to enable real-time access, [...]

United Arab Emirates Ministry of Health and Prevention Approves Biomerica’s Fortel® Ulcer Test for Detection of H. pylori Infection

23/04/2025 - 14:19

10-minute test enables detection of Helicobacter pylori , a leading cause of peptic ulcers, dyspepsia, and gastric cancer Approximately 80% of gastric cancer cases are linked to H. pylori infection; WHO classifies H. [...]

Clearmind Medicine Completes the Initiation of its Alcohol Use Disorder Phase I/IIa Clinical Trial at all Current Clinical Sites

23/04/2025 - 14:25

The Company is now preparing for the enrollment of the first patient to receive Clearmind’s innovative treatment as part of the trial Vancouver, Canada, April 23, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq [...]

Vivos Inc. Achieves Record Growth in IsoPet® Animal Cancer Treatments in Q1 2025

23/04/2025 - 14:30

Kennewick, WA, April 23, 2025 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), a leader in innovative cancer therapies, announced today a record-breaking first quarter for its IsoPet ® Animal Cancer Division. The company’s [...]

Enlivex Therapeutics to Showcase Allocetra’s Potential in Osteoarthritis at OARSI 2025 World Congress

23/04/2025 - 14:30

Presentations to underscore Allocetra TM ’s novel mechanism targeting immune imbalance in joint disease Ness-Ziona, Israel, April 23, 2025 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a [...]